USPTO serial 88732535
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Minneapolis, MN
MINNEAPOLIS, MN
MINNEAPOLIS, MN
MINNEAPOLIS, MN
MINNEAPOLIS, MN
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
HEATHER KLIEBENSTEIN
HEATHER KLIEBENSTEIN MERCHANT & GOULD P.C.P.O. BOX 2910MINNEAPOLIS, MN 55402UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Epigenetic test kits comprising reagents for testing and analyzing saliva for non-medical purposes; Reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic purposes | ACTIVE | — |
| 005 | Medical diagnostic reagents; Clinical medical diagnostic reagents | ACTIVE | — |
| 009 | Computer systems, namely, computer hardware, downloadable computer software, and downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, and excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers; Downloadable computer software for data collection, management, and analysis of molecular health, genetic and epigenetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers | ACTIVE | — |
| 036 | Annuity underwriting; Insurance information and consultancy; Insurance services, namely, insurance eligibility review and verification and consultation in the life insurance industry; Insurance services, namely, underwriting, issuing and administration of life and long-term care insurance and annuities | ACTIVE | — |
| 041 | Providing an online resource center, namely, online non-downloadable articles and papers in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing a website featuring online non-downloadable publications in the nature of articles, journals, brochures, leaflets, guides and manuals in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing an online publication in the nature of an non-downloadable interactive encyclopedia in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Educational services, namely, providing seminars, workshops, customer trainings and tutorials in the fields of, and for use in the fields of, health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Providing non-downloadable electronic newsletters and online non-downloadable electronic newsletters delivered via email for use in the fields of health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Educational services, namely, providing training of clinicians, scientists, researchers and medical professionals in the use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus; Providing facilities for training in operation and use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus | ACTIVE | — |
| 042 | Providing scientific analysis in the field of personal epigenetics; Reporting of consumer authorized molecular health, aging and longevity results direct to the consumer for non-medical purposes, namely, epigenetic testing, analysis and evaluation of saliva; Testing, analysis and evaluation of DNA for epigenetic patterns associated with alcohol and tobacco use and other traits about an individual for non-medical purposes; Providing an interactive website featuring technology that allows users to enter, access, track, monitor and generate information and reports in the fields of personal epigenetics, health and wellness | ACTIVE | — |
| 044 | Medical testing for screening, diagnostic or prognostic purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; Nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; Genomic sequencing, screening, and analysis services for medical diagnostic purposes; Genetic and epigenetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillance | ACTIVE | — |
| 045 | Online social networking services in the field of longevity, aging, genetics and epigenetics | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 22, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 19, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 9, 2023 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Aug 9, 2023 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 9, 2023 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Mar 2, 2023 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Mar 2, 2023 | OPPF | OPPOSITION PAPERS RECEIVED AT TTAB | — |
| Jan 31, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 31, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 11, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 22, 2022 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Dec 19, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 1, 2022 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 25, 2022 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| May 24, 2022 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 24, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 24, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 4, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 20, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 31, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Nov 17, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 30, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 9, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 9, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 9, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 9, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 9, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 19, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 14, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 14, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 14, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 22, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 21, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 23, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 21, 2019 | NWAP | NEW APPLICATION ENTERED | — |